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Abstract
Medication adherence is a substantial problem in the elderly. It may be even more important
among elderly persons with memory problems, since other factors that lead to non-adherence may
be compounded with the memory problems themselves. The objective was to determine whether a
model that integrates research on medication adherence from several research domains is useful in
understanding adherence in elderly patients. The methodology involved a cross-sectional
observational study using a convenience sample of 63 patients drawn from a university-affiliated
outpatient memory disorders clinic. The primary measure of medication adherence was
caregivers’ reports of patients’ medication adherence. Patients and their caregivers were asked
questions assessing their beliefs about the seriousness of each condition for which a medication
was prescribed and the likely outcome of that condition without treatment. Additional data
collected included presence of side effects, total number of medications taken, and patients’ mood
and cognitive status. Multilevel path analysis confirmed several model-based predictions.
Caregivers’ reports of adherence were predicted by estimates of disease outcome, the presence of
side effects, and patients’ relying on themselves to remember to take medications. Results partially
confirm the integrative model in understanding medication adherence in these patients. Patients’
beliefs about the likely effect of medication treatment for their condition and the presence of side
effects influence reported medication adherence. Results thus suggest that efforts to educate
patients about the likely response of their medical condition to treatment and to assess and deal
with medication side effects might improve patient adherence.
Introduction
The report on medical errors of the Institute of Medicine (Kohn, Corrigan & Donaldson,
2000) identified medication non-adherence as an important source of medical errors. Low
levels of adherence may decrease the effects of prescribed medications or other treatments
and increase the likelihood of poor outcomes (McDonald, Garg & Haynes, 2002). Close
relations between adherence and intermediate clinical outcomes have been demonstrated for
a number of diseases, and a significant number of adverse events have been linked to non-
adherence among the elderly (Gurwitz, Field & Harrold, 2003).
© 2006 Taylor & Francis
Correspondence: Dr. R. L. Ownby, Department of Psychiatry, Mt. Sinai Medical Center, MRI Building 2nd Floor, 4300 Alton Road,
Miami Beach, FL 33140, USA. rownby@med.miami.edu.
NIH Public Access
Author Manuscript
Aging Ment Health. Author manuscript; available in PMC 2013 January 11.
Published in final edited form as:
Aging Ment Health. 2006 July ; 10(4): 378–385. doi:10.1080/13607860500410011.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Low levels of adherence to prescribed medications have been documented in older adults
with a number of chronic diseases, including hypertension (Bobb-Liverpool, Duff & Bailey,
2002), congestive heart failure (Evangelista et al., 2003), statin treatment in patients with
cardiovascular disease (Applegate, 2002) and asthma (Barr, Somers, Speizer & Camargo,
Jr., 2002). Evidence has shown that cognitive and memory problems may play an important
role in medication adherence (Ganguli et al., 2004; Salas et al., 2001), but few readily-
identifiable studies have explicitly examined the role of cognitive factors in adherence
among patients with known memory problems that do not preclude self care, such as mild
cognitive impairment (MCI) or early Alzheimer’s disease (AD).
Medication adherence is a complex behavior that can be influenced by patient beliefs and
knowledge, patient characteristics such as socioeconomic status, depression, and age, and
the methods by which patients try to remember to take their medications. The Health Belief
Model (Janz & Becker, 1984), for example, implies that medication adherence will be
related to patients’ beliefs about the seriousness of their disease, the likelihood that the
medication will affect the disease and obstacles they encounter in taking their medication.
Other social cognitive theories similarly specify that patient beliefs about the nature of the
disease and its treatment are likely to influence health behaviors such as medication
adherence (Leventhal, Leventhal, Robitaille & Brownlee, 1999). Patient characteristics that
may influence levels of medication adherence include age, education, and socioeconomic
status (Dunbar-Jacob & Schlenk, 2001). Depression may also be a particularly important
factor in medication adherence (DiMatteo, Lepper & Croghan, 2000), and patients’ memory
functioning is also important. Finally, it is likely that medication adherence can be affected
by the means by which patients remember to take their medications (Park, Morrell, Frieske
& Kincaid, 1992). Survey data (Gould, 1999) show that older adults’ strategies for
remembering can be grouped into internal (for example, trying hard to learn about
medication instructions) and external (leaving the pills in a prominent place) groups.
In attempt to integrate these different areas of research, Park and Jones (1997) suggest that
there are three general approaches to understanding adherence: (a) a focus on patient beliefs
about their illness; (b) a focus on how patient characteristics affect medication adherence;
and (c) a focus on mnemonic strategies, such as pillboxes or reminders to assist patients in
adherence. Park and Jones (1997) organize observations about each area’s contribution to
understanding adherence into an integrative theory of medication adherence. This theory is
appealing because it strives to reconcile different approaches to understanding medication
adherence.
No readily identifiable study has investigated medication adherence in patients with memory
disorders. This group of persons may be especially at risk for non-adherence, given their
memory deficits. A better understanding of adherence in this group may thus be desirable.
Further, confirming the validity of the Park and Jones (1997) theory for understanding
medication adherence in the elderly might provide a useful tool for investigations of
medication adherence in this group. The purpose of this study was thus to investigate factors
related to adherence in patients seen at a memory disorders clinic in the context of the Park
and Jones model.
Method
Medication adherence was studied in a convenience sample of 75 patients evaluated at a
universityaffiliated memory disorders clinic. Of these 75, 63 had caregivers who could
provide sufficient data to be used in subsequent analyses of adherence. Patients with
memory disorders who were willing to complete an additional questionnaire during routine
evaluation or follow-up visits to the clinic participated in the study. Data collected were
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selected to represent the domains described by the Park and Jones (1997) model of
medication adherence. In the area of disease representation, a questionnaire was developed
that assessed patients’ views of their illnesses and the medication used in their treatment.
This questionnaire asked patients what medications they took and for what purpose. For
each medication, patients were asked to rate on a five-point Likert-type scale the seriousness
of the condition for which the medication was taken and the likely outcome if medication
were not taken as directed. Both patients and their caregivers were asked how often the
patient took the medication on a five-point scale, ranging from ‘Almost never’ to ‘Almost
always’. For each medication, patients were asked how they remembered to take their
medication. Methods reported fell into three main groups: (a) remembering by oneself,
usually by incorporating taking the medication into a daily routine such as having breakfast
but not using any aid such as a calendar or pillbox; (b) reliance on another person, usually a
spouse or other caregiver; and (c) reliance on a mechanical aid such as a pillbox with
sections for each day’s doses.
Finally, patients were asked whether they experienced any side effects from each
medication, and if so, what they were. Information obtained from the questionnaire thus also
allowed assessment of the total number of medications taken by each patient. Information
about how patients remembered to take medication allowed assessment of the portion of the
Park and Jones model that focuses on the use of external memory supports. For data
analyses, this item was collapsed into a single binary item reflecting whether or not the
patient relied on him or herself or a caregiver or mechanical aid to remember to take his or
her medication. The resulting questionnaire is available from the authors. It may be noted
that although this questionnaire was specifically designed to assess aspects of the Park and
Jones (1997) model, some questions were similar to those used in other questionnaires
designed to assess the relation of medication beliefs and adherence (Horne, Weinman &
Hankins, 1999).
Additional data were collected to assess patient characteristics, the third portion of the Park
and Jones (1997) model. Patient cognitive status was assessed through scores on the Mini-
mental Status Exam (MMSE) and patient mood was assessed through administration of the
Hamilton Depression Rating Scale (HAM-D). Data on patient age, preferred language (i.e.,
Spanish or English), and educational attainment were obtained from patient records.
Data on patient diagnoses were grouped according to the first diagnosis listed in the
patient’s medical chart. ‘Dementing illnesses’ included possible and probable Alzheimer’s
disease, vascular dementia, and all other causes of dementia. ‘Psychiatric illnesses’ included
diagnoses of mood and anxiety disorders, including major depression, dysthymic disorder,
generalized anxiety disorder, and anxiety disorder not otherwise specified. Medications were
categorized on the basis of the medication type and the purpose for which it was prescribed.
Psychiatric medications included antidepressants, anxiolytics, antipsychotics,
anticonvulsants prescribed for behavior problems, and medications prescribed for insomnia.
Memory-related medications included cholinesterase inhibitors and memantine. General
medical medications included medications prescribed for all other causes, including
hypertension, dyslipidemias, diabetes mellitus, arthritis, hypothyroidism, and all similar
conditions.
Data were collected in three waves by three interviewers who were psychiatrists completing
specialized training in geriatric psychiatry under the supervision of a board-certified
geriatric psychiatrist. Data for each wave were collected during consecutive academic years
during which the psychiatrists completed fellowship training so that data were collected by
different assessors over one of three years. Relations among variables in these data were
thus potentially related to the individual characteristics of specific raters over the years
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during which data were collected. In addition, most patients reported taking more than one
medication so that each patient-caregiver dyad provided ratings for a distinct group of
medications. For example, a single patient might have provided ratings for a set of
medications that included treatments for diabetes, hypertension, and dyslipidemias. Multiple
ratings provided by patients were thus potentially intercorrelated as a result of each patient’s
distinct viewpoint on his or her medications—any given patient, for example, might
consistently over- or underrate the seriousness of his or her medical conditions or any other
of the requested ratings.
Potential sources of variability in the data collected thus included the effects of the
individual psychiatrists involved in data collection during different periods and the effects of
individual patients who reported on groups of medications. Since data arose from several
levels (clustered within patients and within the three samples), variables were potentially
correlated within these levels. Traditional linear regression or path analysis would not take
these intercorrelations into account in evaluating model parameters and thus might produce
incorrect parameter estimates. These are usually incorrect estimates of parameters’ standard
errors that in turn result in incorrect estimates of the statistical significance of the same
parameter estimates (Singer, 1998). Relations among model variables were therefore
analyzed in a multilevel path analytic model using PROC MIXED in SAS (Littell, Milliken,
Stroup & Wolfinger, 1996). This approach allowed estimation of path relations among
model variables and reported medication adherence while taking into account
intercorrelations among variables resulting from the sample membership and from having
obtained multiple rating from most patients.
It was recognized that patient and caregiver reports of adherence might differ, and further
that differences might be related to the techniques patients reported they used to remember
to take their medications. Differences between caregiver and patient reports of adherence
were therefore evaluated across groups defined by reported techniques used to remember to
take medications. A difference score was first calculated by subtracting patient report of
adherence from the corresponding caregiver report, and then t-tests were used to evaluate
between-group differences. Cases were weighted by the total number of medications taken
by each patient to account for different number of medications reported by patients. The
difference in magnitude of the patient-caregiver discrepancies for groups defined by
reported mnemonic strategy was also tested via a t-test weighted for number of medications
taken. In order to correct for the number of comparisons inherent in the use of several t-tests,
the Bonferroni correction was used, resulting in the use of an alpha value of 0.01 (0.05
divided by the number of t-tests, five) in assessing results for statistical significance.
Since a large number of variables were thus collected, a multi-step data reduction procedure
was employed in which two separate models of predictors were developed, and a final
integrative model was formulated. First, a model of caregiver report of adherence was
created that assessed the contributions of ratings of disease and treatment, patient, and
environment variables to caregiver reports of medication adherence. Caregiver report was
used as the dependent variable in these analyses since it was judged that caregiver report
would more accurately reflect patients’ adherence. The hypothesized model specified that
patient beliefs about disease (perceived outcome and seriousness) and treatment variables
(regimen complexity as indexed by the total number of medications taken and presence of
side effects) would predict caregivers’ reports of patient adherence.
A second model also assessed the relation of patient variables (age, HAM-D and MMSE
scores, and education) to caregivers’ reports of adherence. The one environment variable
available for analysis (medication reminder category) was also hypothesized to predict
reported adherence. Finally, based on previous work, depression as measured by the HAM-
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D was hypothesized to predict the presence of side effects and to have a negative relation to
MMSE score. Age was predicted to have an inverse relation with MMSE score, while
educational attainment was predicted to have a positive relation to MMSE score.
The first multilevel regression analysis thus assessed the relation of disease representation
variables to adherence, while the second evaluated the patient characteristic variables in
combination with the single environment variable (memory strategy). Variables that
predicted adherence at a statistical significance of p<0.10 in each of these analyses were
retained for inclusion in a third overall model. Model-based predictions of the relations
among HAM-D, age, and MMSE scores were evaluated in separate analyses.
This study and subsequent data analyses were carried out under protocols approved by the
Mt. Sinai Medical Center Institutional Review Board and the University of Miami Human
Subjects Review Office.
Results
Descriptive data for the sample are presented in Tables I and II. It may be noted that the
percentages reported in Table I for type of medication represent the percent of total
medications rather than the percent of patients receiving a medication. Results of
comparisons of differences between patient and caregiver reports of adherence compared for
groups defined by method of remembering to take medications are reported in Table III.
These results show that the discrepancy between patient and caregiver reports was greatest
for the group of patients who reported relying on themselves or their daily routine to
remember to take their medications. The difference was smaller, although still statistically
significant, for the group that reported relying on a caregiver or spouse. The difference was
smallest for patients who reported using a pillbox or other mechanical aid to remember to
take medications. In this case, the average caregiver rating of adherence was actually higher
than that reported by patients, although this difference was not statistically significant. The
interpretation of this difference is limited by the small number of patients who reported
using a pillbox or other device. The test for the size of the discrepancy between patient and
caregiver reports for groups relying on themselves and on caregivers was also statistically
significant. The size of the patient-caregiver reporting discrepancy was thus significantly
larger in the group that relied on themselves to take their medication.
Results of the multilevel regression analysis of the disease representation model are
presented in Table IV. Of the four disease representation variables, ratings of likely outcome
without treatment and the presence of side effects were related to reported adherence. The
analysis for patient characteristic variables is also reported in Table IV. Of this group of
variables, age and memory strategy were related to adherence. Outcome (patients’ estimate
of likely outcome if the medication were not to be taken) is included in this analysis because
in preliminary analyses it was found to have a significant moderating effect on estimates of
the relation between patient characteristic variables and caregiver estimates of medication
adherence. As these analyses showed that outcome would be included in the final multilevel
analysis and that it had a significant effect on other variables in the model, it was included in
analyses of patient characteristic variables. Table V presents results of analyses of relations
among depression, side effects, and cognitive status. Of the predicted relations, only the
inverse relation between age and MMSE score was significant.
Follow-up analyses in this exploratory study investigated the relations of ratings of disease
seriousness to other variables in the model. Ratings of condition seriousness were related to
perceived outcome and reliance on self as a memory strategy but not directly to reported
adherence. After the initial evaluations, we recomputed the model including only the
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significant coefficients from earlier models. This reduced model is presented as a path
diagram in the Figure 1. The figure also illustrates results of the investigation of the relation
of ratings of condition seriousness to other variables. Patients’ ratings of the seriousness of
their condition did not directly predict adherence, but predicted perceived outcome without
treatment and were inversely related to reliance on self as memory strategy.
In summary, perceived outcome and patient age were positively related to reported
adherence, while the occurrence of side effects and reliance on self to remember were
negatively related to adherence. Age was inversely related to cognitive status as measured
by the MMSE but positively related to adherence. Scores on the MMSE in turn predicted
reliance on one’s self to remember to take medications. Perceived seriousness of the
condition for which the medication was taken was positively related to perceived outcome,
and negatively related to the use of one’s self to remember to take medications.
Discussion
Results of this study thus partially confirm the notion that multiple influences affect
medication adherence in older adults who are patients at a memory disorders clinic.
Consistent with the contention implicit in the Park and Jones (1997) model, patients’
perceptions of their illness, the treatment they receive, their personal characteristics, and
their use of memory strategies may be related to adherence. Patients’ beliefs about the how
serious a medical condition were related to their understanding of the likely outcome of the
condition without treatment. This understanding was in turn related to adherence.
Motivational factors may thus play an important role in adherence in this population.
Consistent with the model’s prediction, relying on a caregiver improved medication
adherence.
It is noteworthy that increasing age was positively related to adherence. This is contrary to
the stereotype that older individuals are less likely to be adherent, but consistent with finding
reported by Park et al. (1999) in a study of adherence in patients with rheumatoid arthritis.
In that study, older patients had higher levels of adherence when compared with younger
patients, who reported being busy and having erratic schedules that interfered with
remembering to take their medications. It may thus not be age by itself that has a negative
impact on adherence, but rather other variables that include patients’ understanding and
motivation as well as their cognitive and memory status. An alternative explanation might
be that older adults who have mild to moderate cognitive impairment may have sufficient
insight into the potential implications of not taking their medication to give them greater
motivation to adhere to prescribed medication regimes. Perhaps as these patients age they
become more aware of the impact of medications on their health status and are more
strongly motivated to adhere to their medications. This finding thus highlights the complex
nature of medication adherence in older adults and the elderly and suggests further needs for
research. If these hypotheses are supported in future research, they might provide bases for
designing new and more effective interventions to improve elders’ medication adherence.
Several predicted relations were not found. Contrary to expectations, regimen complexity as
indexed by the total number of medications was not related to adherence. Depressed mood
did not have a negative relation with general cognitive status, and education did not have a
positive relation with it. These results may be the result of a small sample with limited
power to detect these relations, and clarification of this issue will require a larger study.
The total number of medications per patient found in this study (3.7) is somewhat lower than
that found in several other studies (van Dijk et al., 1998; Williams, Nichol, Yoon, McCombs
& Margolies, 1999; Golden et al., 1998). For example, Golden et al. (1998) found that the
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average number of medications per person in a large sample of homebound elderly was 5.3,
with a standard deviation of 2.9. These estimates are drawn from populations of persons
who may have been more ill than the patients in the present study. It may be noted as well
that in the study by Golden et al. (1998) there was substantial variability in number of
medications, so that our current results are within the range that might be expected. Finally,
since these data are based on self reports from patients and caregivers, it is possible that they
failed to report all medications.
Since both patients and their caregivers or spouses reported estimates of the patients’
adherence to their medications, it was possible to examine differences between patient and
caregiver reports of adherence. This was especially useful in light of the different mnemonic
strategies used by patients. Under the assumption that caregivers’ reports were more likely
to be accurate than patients’ it was thus possible to compare the two sets of reports in the
context of reported mnemonic strategy. Results showed a larger discrepancy between patient
and caregiver report of adherence for the group of patients who stated that they relied on
themselves or their daily routine when compared to those who relied on caregivers’
reminders. This finding suggested that the size of the differences might be larger in the
group that reported relying on themselves than in the group who relied on caregivers. This
was true, as the size of the differences in the two groups was significantly different between
two groups. This thus may imply that patient reports of adherence are less likely to be
accurate than are the reports of their caregivers.
Several limitations of this study should be acknowledged. Reliance on caregiver report of
medication adherence is potentially inaccurate. Other studies have shown that self-report
measures of medication adherence consistently overestimate level of adherence, so that this
reliance is a potential source of inaccuracy. Other, more accurate, measures of medication
adherence such as electronic monitoring of medication use are available but were not used in
this study due to its limited scope.
A second limitation of this study is the nature of the sample used. Patients were selected for
evaluation in the study on the basis of their availability. Since patient selection was not
random, it is difficult to assess the effects of potential selection biases on results. Patients in
this study had been referred for psychiatric evaluation and treatment, so that the sample was
less likely to include patients with memory problems but without concomitant or primary
psychiatric diagnoses. Not all patients were judged to have a primary diagnosis of dementia,
so that the sample was heterogeneous. Although from one perspective a limitation, this
heterogeneity may more accurately reflect the general population served by a memory
disorder clinic.
It should be noted that this sample included patients who were initially seen for evaluation
of memory problems, although as a result of this evaluation some were judged to have
primary psychiatric diagnoses and were therefore treated for psychiatric problems such as
depression and agitation as well as memory problems. Sample size in this study is another
issue. Given the exploratory nature of this study, a small sample was judged acceptable, but
as noted above the path analytic model employed in data analysis may have had limited
power to detect predicted relations among study variables.
This study thus suggests that Park and Jones’ (1997) central contention in creating their
model may be correct in that information from several domains may be related to
medication adherence in the elderly. This study shows that patient beliefs, treatment
characteristics, patient characteristics, and memory strategies all may contribute to
adherence. Results thus support the usefulness of this approach for understanding the
complex behavior of taking specific medications in specific ways. Implications of these
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findings are that interventions that target patient beliefs about their medication and that
minimize the occurrence of side effects may be useful in improving medication adherence.
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Figure 1.
Final multilevel path model. Numbers on lines are the standardized regression coefficients
for the relation between variables.
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Table I
Sample characteristics for categorical variables.
Characteristic Number Percentage
Language/cultural background
 Hispanic 28 44.4
 Anglo 35 55.6
Gender
 Male 18 28.6
 Female 45 71.4
Memory strategy used
 Self/routine 89 34.5
 Caregiver/spouse 129 54.9
 Pillbox/other aid 11 4.7
Presence of side effects
 Yes 24 10.2
 No 211 89.8
Sample
 1 26 41.3
 2 21 33.3
 3 16 25.4
Medication category
 Psychiatric 81 34.5
 Memory-related 38 16.2
 General medical 116 49.4
Primary diagnosis
 Dementing illness 49 77.8
 Psychiatric illness 14 22.2
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Table II
Descriptive statistics for continuous study variables.
Variable Mean SD Range
Age 76.3 7.9 34
Educational level (years) 11.5 3.8 16
HAM-D 8.3 6.0 28
MMSE 19.8 8.0 30
Total number of medications taken 3.7 1.5 6
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